BTN2A2, a new biomarker and therapeutic target for glioma

Background: Protein casein 2A2 (BTN2A2) is a costimulatory molecule first identified in antigen-presenting cells. Studies have shown the involvement of BTN2A2 in immunity. However, the exact role and the mechanism of BTN2A2 in tumors are still unclear. Methods: First, we performed real-time PCR to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Heping, Pu, Shanrui, Xu, Haitao, Yang, Lihong, Shao, Lishi, Chen, Xi, Huang, Xiaobin, Pu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637821/
https://www.ncbi.nlm.nih.gov/pubmed/37851374
http://dx.doi.org/10.18632/aging.205039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637821/
https://www.ncbi.nlm.nih.gov/pubmed/37851374
http://dx.doi.org/10.18632/aging.205039

Ejemplares similares